Biofrontera Inc (BFRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,356 | -4,752 | -10,536 | -16,176 | -9,527 |
| Depreciation Amortization | 383 | 187 | 868 | 648 | 441 |
| Accounts receivable | 1,706 | 3,413 | -1,907 | 2,365 | 1,418 |
| Accounts payable and accrued liabilities | 2,461 | 1,780 | -2 | 1,782 | 2,412 |
| Other Working Capital | 2,161 | 3,804 | -3,484 | 3,974 | 2,019 |
| Other Operating Activity | -3,083 | -4,502 | 1,700 | -3,578 | -3,925 |
| Operating Cash Flow | $-1,728 | $-70 | $-13,361 | $-10,985 | $-7,162 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -5 | -2 | -3 | -4 |
| Other Investing Activity | 0 | 0 | 3,000 | 0 | 0 |
| Investing Cash Flow | $-5 | $-5 | $2,998 | $-3 | $-4 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 8,500 |
| Other Financing Activity | 0 | 0 | 10,850 | 8,500 | 0 |
| Financing Cash Flow | $N/A | $N/A | $10,850 | $8,500 | $8,500 |
| Beginning Cash Position | 6,592 | 6,592 | 6,105 | 6,105 | 6,105 |
| End Cash Position | 4,859 | 6,517 | 6,592 | 3,617 | 7,439 |
| Net Cash Flow | $-1,733 | $-75 | $487 | $-2,488 | $1,334 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,728 | -70 | -13,361 | -10,985 | -7,162 |
| Capital Expenditure | -5 | -5 | -2 | -3 | -4 |
| Free Cash Flow | -1,733 | -75 | -13,363 | -10,988 | -7,166 |